Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $462,487 - $772,047
10,900 Added 26.46%
52,100 $3.55 Million
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $1.55 Million - $2.78 Million
-37,500 Reduced 47.65%
41,200 $1.74 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $163,183 - $213,933
2,900 Added 3.83%
78,700 $5.44 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $608,318 - $779,916
10,300 Added 15.73%
75,800 $5.61 Million
Q3 2023

Nov 15, 2023

BUY
$65.94 - $99.04 $4.32 Million - $6.49 Million
65,500 New
65,500 $4.47 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.